Comparative evaluation of hepatitis C virus RNA quantitation by branched DNA, NASBA, and monitor assays.
about
Performance characteristics of the COBAS Amplicor Hepatitis C Virus (HCV) Monitor, Version 2.0, International Unit assay and the National Genetics Institute HCV Superquant assayEvaluation of the VERSANT HCV RNA 3.0 assay for quantification of hepatitis C virus RNA in serumComparative Evaluation of the Total Hepatitis C Virus Core Antigen, Branched-DNA, and Amplicor Monitor Assays in Determining Viremia for Patients with Chronic Hepatitis C during Interferon Plus Ribavirin Combination TherapyRapid and early virological response to chronic hepatitis C treatment with IFN 2b or PEG-IFN 2b plus ribavirin in HIV/HCV co-infected patientsExpertise of French laboratories in detection, genotyping, and quantification of hepatitis C virus RNA in serumEvaluation of quantitative PCR and branched-chain DNA assay for detection of hepatitis B virus DNA in sera from hepatocellular carcinoma and liver transplant patients.Clinical evaluation of the automated COBAS AMPLICOR HCV MONITOR test version 2.0 for quantifying serum hepatitis C virus RNA and comparison to the quantiplex HCV version 2.0 test.Review of the effect of highly active antiretroviral therapy on hepatitis C virus (HCV) RNA levels in human immunodeficiency virus and HCV coinfection.Molecular diagnosis of influenza.Response to interferon alpha treatment and disappearance of cryoglobulinaemia in patients infected by hepatitis C virusAnalytical and biological variables influencing quantitative hepatitis C virus (HCV) measurement in HIV-HCV coinfection.Multiplex nucleic acid sequence-based amplification for simultaneous detection of several enteric viruses in model ready-to-eat foods.Hepatitis C core Ag and its clinical applicability: potential advantages and disadvantages for diagnosis and follow-up?Hepatitis C virus quantitation: optimization of strategies for detecting low-level viremia.Assessment of viral loads in patients with chronic hepatitis C with AMPLICOR HCV MONITOR version 1.0, COBAS HCV MONITOR version 2.0, and QUANTIPLEX HCV RNA version 2.0 assays.Analytical variables influencing the HCV RNA determination by TaqMan real-time PCR in routine clinical laboratory practice.Long-term evolution of serum and liver viral markers in patients treated for chronic hepatitis C and sustained response.Comparison between three quantitative assays in patients with chronic hepatitis C and their relevance in the prediction of response to therapy.Immunohistochemical detection of hcv in cirrhosis, dysplastic nodules, and hepatocellular carcinomas with parallel-tissue quantitative RT-PCR.Performance characteristics of a transcription-mediated nucleic acid amplification assay for qualitative detection of hepatitis C virus RNA.Fluctuation of serum HCV-RNA levels in untreated blood donors with chronic hepatitis C virus infection.Early viral clearance and sustained response in chronic hepatitis C: a controlled trial of interferon and ribavirin after high-dose interferon induction.Evaluation of the clinical usefulness of COBAS AMPLICOR HCV MONITOR assay (ver2.0): Comparison with AMPLICOR HCV MONITOR assay (ver1.0) and HCV core protein level.
P2860
Q27471191-E875C6A2-3CDA-4A9A-9367-811EEC2C1C68Q27472747-AC83E34F-9B1F-495F-9B13-6F8BE63A4751Q27477674-0D0E8DA5-D3E8-4B58-8E95-72895CC0015CQ27481046-9612C835-D6C3-4923-8746-00A81BE0F9E5Q33712557-B5EF2640-E190-4C31-B3C0-44D07F1D65ECQ33967029-82ADF87B-C404-4D9B-8936-0D8E4AB012FEQ33968828-BEB09E8E-D4E1-458D-ADA5-510EE17C65E7Q34849390-5BC964BE-481C-49B4-8B03-0726C31A3F23Q34985863-6232C3AE-3304-4004-9B04-1A90310C671BQ35355811-FAE272D6-6783-4703-BCCA-8FC97EF19B9BQ36375990-3512A7DF-9DE0-4986-A08D-832E67EA9424Q37597231-9AC6053A-C477-465A-8AE4-C721396EA30CQ37961619-1E42B4F7-2BAB-4B9F-BFF0-C9012D7759F6Q39455553-07DBD101-A739-4E70-B3DB-122319C3A2E2Q39459300-E021FD35-0C76-4DF6-9C3C-4F969E6686C9Q42977638-946474ED-5505-44D6-9B51-F6C22216665AQ42997222-7DBF4F74-FB40-46F2-97B6-EB53B42BD524Q42998943-60209009-7B16-4983-845B-44BC2CB0792CQ43031510-23B44204-F4A5-490F-BF2C-50CFEE7B5A7AQ43036076-E647147A-D3A9-49AD-BB1F-59889158D3B4Q43036608-6C102B32-E6CC-4E34-90F1-2C90D358C74AQ43039959-54AE2B74-B755-4BC3-B3D6-2FECBEA98F5CQ43040005-42C4987A-BB4B-4DA9-8EBF-5E0D390AC654
P2860
Comparative evaluation of hepatitis C virus RNA quantitation by branched DNA, NASBA, and monitor assays.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年学术文章
@wuu
1999年学术文章
@zh
1999年学术文章
@zh-cn
1999年学术文章
@zh-hans
1999年学术文章
@zh-my
1999年学术文章
@zh-sg
1999年學術文章
@yue
1999年學術文章
@zh-hant
name
Comparative evaluation of hepa ...... NA, NASBA, and monitor assays.
@en
Comparative evaluation of hepa ...... NA, NASBA, and monitor assays.
@nl
type
label
Comparative evaluation of hepa ...... NA, NASBA, and monitor assays.
@en
Comparative evaluation of hepa ...... NA, NASBA, and monitor assays.
@nl
prefLabel
Comparative evaluation of hepa ...... NA, NASBA, and monitor assays.
@en
Comparative evaluation of hepa ...... NA, NASBA, and monitor assays.
@nl
P2093
P356
P1433
P1476
Comparative evaluation of hepa ...... NA, NASBA, and monitor assays.
@en
P2093
Frangeul L
P304
P356
10.1002/HEP.510290237
P407
P577
1999-02-01T00:00:00Z